Market Overview

Abiomed Wins Federal Contract to Provide Impalla Platform to Vets

Share:
Related ABMD
Jim Cramer Gives His Opinion On Synergy Pharmaceuticals And ABIOMED
Abiomed's Stock Gains Following Positive Q3, Revised Guidance
ABIOMED's (ABMD) CEO Michael Minogue on Q1 2017 Results - Earnings Call Transcript (Seeking Alpha)

Abiomed, Inc. (Nasdaq: ABMD), a leading provider of breakthrough heart support technologies, today reported that it received approval from the U.S. Department of Veterans Affairs to be included on its authorized Veteran's Administration (VA) Federal Supply Schedule in which Abiomed can provide the Impella® platform to VA medical facilities, Department of Defense (DOD) hospitals and other federal agencies.

This contract allows the Company to make the Impella platform available through an automated online database for the approximately 169 VA facilities and the approximately 42 DOD hospitals in the United States. The five year contract will run until August 2018.

Posted-In: News

 

Related Articles (ABMD)

View Comments and Join the Discussion!